Loading organizations...
§ Private Profile · London, United Kingdom
Provides reproductive health benefits and clinical support for corporate employers, covering fertility, family-forming, and women's health.
Based in London, England, Fertifa is a digital health platform that provides corporate employers with reproductive and family-forming benefits, encompassing clinical support, education, and financing administration. The company operates an application that connects employees directly with an in-house clinical team for specialist advice, diagnostic testing, and medication delivery. These services cover a broad spectrum of medical needs, including in vitro fertilization, menopause, men's sexual health, surrogacy, adoption, and neurodiversity challenges. Operating with a team of 22 employees, the enterprise experienced a tenfold increase in annual revenue prior to securing a £5 million seed funding round in June 2023. This capital injection was led by Notion Capital and Triple Point Ventures, supporting a corporate client roster that features organizations such as Meta, Lululemon, and Bain Capital. Fertifa was founded in 2019 by Tony Chen and Nick Kuan.
Fertifa has raised $7.0M across 2 funding rounds.
Fertifa has raised $7.0M in total across 2 funding rounds.
Fertifa has raised $7.0M in total across 2 funding rounds.
Fertifa's investors include Notion Capital, Manuel Antunes, AI Fund, AirAngels, Balderton Capital, C2 Investment, Encomenda Smart Capital, Endeavor Venture Funds, Felix Capital, Founder Collective, Homebrew, Lightspeed Venture Partners.
Fertifa is a London-based medtech company that provides an online platform delivering reproductive health benefits to employees, enabling employers to offer comprehensive support for fertility, family-forming, menopause, and related health issues.[1][2][3][5] It serves companies of all sizes across sectors like financial services, retail, and tech—including clients such as Lululemon, Meta, Bain Capital, and Virgin—through a per-employee-per-month pricing model plus a 5% fee on transaction volume for reimbursements.[1][3] Fertifa solves the care gap in European reproductive health by facilitating services like egg freezing, IVF, contraception, surrogacy, endometriosis care, and men's sexual health, while handling claims compliance and saving employers £250,000 and patients over £1.5 million in the past year.[1][3] The company has shown strong growth, with revenues increasing 10x in the last year and client numbers quadrupling since early 2022, positioning it as a challenger in virtual/hybrid fertility clinics alongside Maven and Progyny.[1][2]
Fertifa was founded in 2019 by Tony Chen and Nick Kuan, who have since departed but remain shareholders.[1] The idea emerged to address overlooked reproductive health gaps in European public systems and private insurance, drawing parallels to U.S. payer models.[1][3] A pivotal moment came in January 2022 when Eileen Burbidge, from Passion Capital, joined as executive director after leading the pre-seed round with partner Malin Posern; she now leads business development.[1][2] Early traction included a £1 million (~$1.3 million) round from Passion Capital and angels, followed by a £5 million (~$6.3 million) seed in June 2023 led by Notion Capital and Triple Point Ventures, bringing total funding to ~$7.6 million.[1][4] With 22 employees as of mid-2023, Fertifa quickly built a client base and scaled revenues 10x.[1]
Fertifa rides the rising demand for workplace fertility and reproductive benefits, driven by competitive talent markets, DEI initiatives, and awareness of care gaps in overburdened European public health systems.[1][2][3] Timing aligns with U.S.-style precedents adapting to Europe, where such benefits enhance employer competitiveness amid low fertility rates and hormonal health needs.[1][3] Market forces like telehealth growth in digital health and women's health tech (e.g., virtual clinics, at-home testing) favor it, positioning Fertifa as a UK leader expanding to EMEA.[1][2] It influences the ecosystem by normalizing corporate reproductive support, reducing reliance on public care, and fostering healthier workforces, as seen in its challenger status among 13 firms like Progyny.[2]
Fertifa is poised to dominate UK reproductive benefits within a year of its 2023 funding, then lead EMEA by end-2024 via new services like treatment financing and enterprise sales scaling.[1] Trends like hybrid fertility clinics, menopause/neurodiversity support, and AI-driven claims will shape its path, amplifying growth in digital health's employee wellness segment.[2][5] Its influence may evolve from UK pioneer to pan-European standard-setter, further closing care gaps and driving corporate adoption as demographics and awareness intensify. This builds on its momentum as a technology company transforming workplace health equity.[1][3]
Fertifa has raised $7.0M across 2 funding rounds. Most recently, it raised $6.0M Seed in June 2023.